Colorectal Cancer
📧 Sign up to get email alerts when something new happens for Colorectal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors [Phase 1]
FT836 is being studied in a Phase 1 trial for advanced solid tumors, administered with or without chemotherapy and/or monoclonal antibodies.…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study of Using Social Networks to Encourage Three Peers to Complete Screening for Colorectal Cancer [NA]
Memorial Sloan Kettering is running a study on using social networks to encourage peers to complete colorectal cancer screening. The trial i…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer [Phase 3]
Phase III clinical trial evaluating Ivonescimab or Bevacizumab in combination with FOLFOX for metastatic colorectal cancer, currently recrui…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Trial Comparing Simple Follow-up to Exploratory Laparotomy Plus "in Principle" (Hyperthermic Intraperitoneal Chemotherapy) HIPEC in Colorectal Patients [Phase 3]
Phase 3 trial comparing simple follow-up to exploratory laparotomy plus HIPEC in colorectal cancer patients with limited peritoneal metastas…
-
CLINICAL_TRIALS withdrawal · 2026-04-06Clinical Trial Update: Study of NGM707 in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies [Phase 2]
A Phase 2 trial of NGM707 in combination with pembrolizumab for advanced or metastatic solid tumors, including colorectal cancer, has been w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Diet Modulation of Bacterial Sulfur and Bile Acid Metabolism and Colon Cancer Risk [NA]
An update on a completed clinical trial investigating whether diet modulates gut sulfur and bile acid metabolism and its effect on colorecta…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Modified Short-Course Radiotherapy Combined With Immunochemotherapy and Targeted Therapy as First-Line Treatment for MSS Metastatic Colorectal Cancer [Phase 2]
A Phase 2 trial is evaluating a modified short-course radiotherapy regimen combined with immunochemotherapy and targeted therapy as first-li…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC) [Phase 1, Phase 2]
A Phase I/II clinical trial evaluating a multi-agent immunotherapy regimen (SX-682, TriAdeno Vaccine, Retifanlimab, and IL-15 agonist N-803)…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Use of a Colorectal Cancer Screening Decision Support Tool in Primary Care [NA]
Study completion for a colorectal cancer screening decision-support tool used in primary care to support shared decision making in screening…
-
CLINICAL_TRIALS withdrawal · 2026-04-06Clinical Trial Update: Monalizumab and MEDI5752 in Patients With MSI and/or dMMR Metastatic Cancer [Phase 2]
Phase 2 trial of Monalizumab and MEDI5752 in MSI/dMMR metastatic colorectal cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: DevelopmentA Web-Based Support Care Program for Individuals Diagnosed With Colorectal Cancer [NA]
This clinical trial update reports completion of a study evaluating a web-based support care program for people diagnosed with colorectal ca…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Phase 2 Trial of Fruquintinib and Tislelizumab in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy [Phase 2]
A Phase 2 trial evaluating Fruquintinib in combination with tislelizumab for ctDNA-defined minimal residual disease in colorectal cancer aft…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer [Phase 1]
Phase 1 clinical trial evaluating autologous T-cells engineered to target KRAS mutations in combination with a KRAS-directed vaccine for met…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: SMYD3-Driven Metabolic Rewiring in Colorectal Liver Metastases
Clinical trial update about SMYD3-driven metabolic changes in colorectal cancer with liver metastases; trial status is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Fruquintinib in Patients With Metastatic Colorectal Cancer
Clinical trial update indicates a study evaluating Fruquintinib for metastatic colorectal cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Fruquintinib In Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies in South Korea Patients (FIRST-K) [Phase 2]
This is a Phase 2 clinical trial update for fruquintinib in patients with metastatic colorectal cancer refractory to standard chemotherapies…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Advanced Therapies for Liver Metastases
Clinical trial update from IRCCS San Raffaele notes ongoing recruitment for advanced therapies targeting liver metastases, with indications …
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: LDRT Combined With Immunochemotherapy for Colorectal Cancer With Liver Metastasis [Phase 1]
Phase 1 clinical trial evaluating low-dose radiotherapy combined with immunochemotherapy for metastatic colorectal cancer with liver metasta…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations [Phase 1]
Phase 1 study to evaluate ALTA3263 in adults with KRAS-mutant advanced solid tumors, including pancreatic ductal adenocarcinoma, non-small c…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials [NA]
A clinical trial update describing efforts to improve adolescent and young adult self-reported data in ECOG-ACRIN trials, with trials curren…
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: 9-ING-41 in Patients With Advanced Cancers [Phase 2]
Actuate Therapeutics' Phase 2 trial of 9-ING-41 in patients with advanced cancers is currently active but not recruiting, with pancreatic ca…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: The Phase-2 CCR5-targeting Leronlimab With Oral Chemotherapy and VEGF-inhibitor Enriched Regimen Trial (CLOVER) [Phase 2]
A Phase-2 trial (CLOVER) evaluating leronlimab with an oral chemotherapy and VEGF-inhibitor-enriched regimen for metastatic colorectal cance…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: FMT Combined With Standard First-Line Therapy in Initially Unresectable Colorectal Cancer [Phase 2, Phase 3]
A phase 2/3 clinical trial is evaluating fecal microbiota transplant in combination with standard first-line therapy for initially unresecta…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Tocotrienol and Bevacizumab in Metastatic Colorectal Cancer [Phase 2]
This clinical trial update describes a Phase 2 study evaluating the combination of tocotrienol and bevacizumab for metastatic colorectal can…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: FL-261 Imaging for Cancer Diagnosis and Staging
A clinical trial named FL-261 for imaging-based cancer diagnosis and staging is currently recruiting, studying its use across multiple cance…